KDNY Annual Cash & Cash Equivalents
$115.44 M
-$66.29 M-36.48%
31 December 2022
Summary:
As of February 1, 2025, KDNY annual cash & cash equivalents is $115.44 million, with the most recent change of -$66.29 million (-36.48%) on December 31, 2022. During the last 3 years, it has risen by +$104.23 million (+930.42%).KDNY Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KDNY Quarterly Cash And Cash Equivalents
$127.15 M
+$8.65 M+7.30%
30 June 2023
Summary:
As of February 1, 2025, KDNY quarterly cash and cash equivalents is $127.15 million, with the most recent change of +$8.65 million (+7.30%) on June 30, 2023. Over the past year, it has dropped by -$18.78 million (-12.87%).KDNY Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KDNY Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.5% | -12.9% |
| 3 y3 years | +930.4% | - |
| 5 y5 years | +930.4% | - |
KDNY Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -38.5% | -32.3% |
Chinook Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $127.15 M(+7.3%) |
| Mar 2023 | - | $118.50 M(+2.6%) |
| Dec 2022 | $115.44 M(-36.5%) | $115.44 M(-8.4%) |
| Sept 2022 | - | $126.07 M(-13.6%) |
| June 2022 | - | $145.93 M(+41.0%) |
| Mar 2022 | - | $103.50 M(-43.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $181.72 M(-3.2%) | $181.72 M(+67.5%) |
| Sept 2021 | - | $108.52 M(-19.9%) |
| June 2021 | - | $135.47 M(-19.4%) |
| Mar 2021 | - | $168.09 M(-10.5%) |
| Dec 2020 | $187.75 M(+1575.9%) | $187.75 M(+158.7%) |
| Sept 2020 | - | $72.57 M(+547.8%) |
| Dec 2019 | $11.20 M | $11.20 M |
FAQ
- What is Chinook Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Chinook Therapeutics?
- What is Chinook Therapeutics annual cash & cash equivalents year-on-year change?
- What is Chinook Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Chinook Therapeutics?
- What is Chinook Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Chinook Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of KDNY is $115.44 M
What is the all time high annual cash & cash equivalents for Chinook Therapeutics?
Chinook Therapeutics all-time high annual cash & cash equivalents is $187.75 M
What is Chinook Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, KDNY annual cash & cash equivalents has changed by -$66.29 M (-36.48%)
What is Chinook Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KDNY is $127.15 M
What is the all time high quarterly cash and cash equivalents for Chinook Therapeutics?
Chinook Therapeutics all-time high quarterly cash and cash equivalents is $187.75 M
What is Chinook Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, KDNY quarterly cash and cash equivalents has changed by -$18.78 M (-12.87%)